Global epidemiology of dyslipidaemias

Area of Science:

• Cardiovascular Medicine
• Metabolic Disorders
• Clinical Biochemistry

Background:

• Dyslipidaemias, alterations in plasma lipid profiles, are linked to various clinical conditions.
• Elevated LDL-cholesterol is a major cardiovascular disease risk factor, with its impact on mortality increasing over time.
• Other forms like hypertriglyceridaemia are associated with non-alcoholic fatty liver disease and acute pancreatitis.

Purpose of the Study:

• To highlight the growing global burden of dyslipidaemias.
• To emphasize the association between dyslipidaemia and increased cardiovascular disease risk.
• To underscore the importance of managing lipid abnormalities, particularly in patients with diabetes and metabolic syndrome.

Main Methods:

• Review of epidemiological data on dyslipidaemia prevalence and mortality trends.
• Analysis of the relationship between specific lipid profiles (LDL-C, triglycerides, HDL-C) and associated diseases.
• Examination of the impact of dyslipidaemia in the context of diabetes and metabolic syndrome.

Main Results:

• The global burden of dyslipidaemias has significantly increased over the last 30 years.
• Elevated LDL-cholesterol has risen as a leading cause of death.
• Atherogenic dyslipidaemia (high triglycerides, low HDL-C, small LDL particles) is highly prevalent in diabetic and metabolic syndrome patients, increasing cardiovascular risk.

Conclusions:

• Dyslipidaemias represent a growing global health challenge with substantial cardiovascular implications.
• Effective management of lipid abnormalities, especially in individuals with diabetes, is essential for reducing cardiovascular disease burden.
• Further research and public health initiatives are needed to address the increasing prevalence and impact of dyslipidaemias.